Scheltens P, Atri A, Feldman H, Hansson O, et al. Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease (P11-9.013). Neurology 2024;102.
PMID: 39977949